Zidesamtinib
(ZYE-deh-SAM-tih-nib)
This page contains brief information about zidesamtinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Jideytro
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Zidesamtinib is approved to treat:
- Non-small cell lung cancer that has spread and has an abnormal ROS1 gene. It is used in adults whose cancer has been treated with a ROS1 kinase inhibitor.
More About Zidesamtinib
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Targeted Therapy to Treat Cancer
Clinical Trials Accepting Patients
Find Clinical Trials for Zidesamtinib - Check for trials from NCI's list of cancer clinical trials now accepting patients.